These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35788259)

  • 1. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.
    Mahler DA; Demirel S; Hollander R; Gopalan G; Shaikh A; Mahle CD; Elder J; Morrison C
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):427-438. PubMed ID: 35788259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
    Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on Physical Position of Peak Inspiratory Flow in Stable COPD: An Observational Study.
    Pleasants RA; Henderson AG; Bayer V; Shaikh A; Drummond MB
    Chronic Obstr Pulm Dis; 2024 Mar; 11(2):174-186. PubMed ID: 38236166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD.
    Mahler DA; Niu X; Deering KL; Dembek C
    Int J Chron Obstruct Pulmon Dis; 2022; 17():559-568. PubMed ID: 35313719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
    Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions.
    Loh CH; Peters SP; Lovings TM; Ohar JA
    Ann Am Thorac Soc; 2017 Aug; 14(8):1305-1311. PubMed ID: 28406710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal Peak Inspiratory Flow in Patients Hospitalized for COPD Exacerbation: Prevalence and Predictive Factors.
    González-Montaos A; Pazos-Area L; Represas-Represas C; Ramos-Hernández C; Lojo-Rodríguez I; Priegue-Carrera A; Aballe-Santos L; Fernández-Villar A
    J Aerosol Med Pulm Drug Deliv; 2024 Oct; 37(5):225-231. PubMed ID: 39388689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.
    Ohar JA; Ferguson GT; Mahler DA; Drummond MB; Dhand R; Pleasants RA; Anzueto A; Halpin DMG; Price DB; Drescher GS; Hoy HM; Haughney J; Hess MW; Usmani OS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():79-92. PubMed ID: 35023914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.
    Mahler DA; Watz H; Emerson-Stadler R; Ritz J; Gardev A; Shaikh A; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1729-1740. PubMed ID: 37599896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease.
    Pleasants RA; Shaikh A; Henderson AG; Bayer V; Drummond MB
    J Aerosol Med Pulm Drug Deliv; 2024 Aug; 37(4):171-179. PubMed ID: 38814000
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
    Amirav I; Newhouse MT; Mansour Y
    Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.
    Pankovitch S; Frohlich M; AlOthman B; Marciniuk J; Bernier J; Paul-Emile D; Bourbeau J; Ross BA
    Chest; 2024 Oct; ():. PubMed ID: 39384100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases.
    Ding N; Zhang W; Wang Z; Bai C; He Q; Dong Y; Feng X; Zhang J; Gao S
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1913-1924. PubMed ID: 34188467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
    Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study).
    Leving M; Wouters H; de la Hoz A; Bosnic-Anticevich S; Dekhuijzen R; Gardev A; Lavorini F; Meijer J; Price D; Rodríguez MR; Tsiligianni I; Usmani O; Wijnsma B; Kocks J
    Pulm Ther; 2021 Dec; 7(2):591-606. PubMed ID: 34533772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data.
    Anderson M; Collison K; Drummond MB; Hamilton M; Jain R; Martin N; Mularski RA; Thomas M; Zhu CQ; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2021; 16():933-943. PubMed ID: 33883890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.
    Malmberg LP; Rytilä P; Happonen P; Haahtela T
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():257-62. PubMed ID: 20714380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Use of Easyhaler
    Kainu A; Vartiainen VA; Mazur W; Hisinger-Mölkänen H; Lavorini F; Janson C; Andersson M
    Pulm Ther; 2024 Mar; 10(1):133-142. PubMed ID: 38170393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.